Please Wait.....
Report
Multimodal Imaging Market - Global Outlook & Forecast 2024-2029
Market Report I 2024-05-16 I 341 Pages I Arizton Advisory & Intelligence
The global multimodal imaging market is expected to grow at a CAGR of 5.35% from 2023-2029.
MARKET TRENDS & DRIVERS
Growing Adoption of AI & Analytics in Diagnostic Imaging
The growing adoption of AI and analytics in diagnostic imaging undoubtedly creates exciting opportunities for the multimodal imaging market. By unlocking the power of complex data, AI has the potential to transform the way we diagnose and treat diseases, leading to improved patient outcomes and a more efficient healthcare system. However, navigating the ethical and regulatory landscape alongside ensuring responsible development will be critical in realizing the full potential of this transformative technology.
Multimodal Molecular Imaging in Drug Discovery and Development
The quest for faster, more efficient, and personalized drug development has led to the emergence of exciting new technologies. Among these, multimodal molecular imaging stands out as a game-changer, revolutionizing the way of visualizing and understanding diseases, ultimately shaping the future of pharmaceutical innovation, and paving the way for a booming multimodal imaging market. Multimodal imaging overcomes this limitation by seamlessly integrating data from multiple imaging modalities, such as PET, MRI, CT, and ultrasound, into a comprehensive picture.
Growing Geriatric Population & Subsequent Rise in Chronic Conditions
Multimodal imaging, the synergistic combination of two or more imaging modalities like PET, MRI, and CT, offers a multifaceted solution to the diagnostic challenges posed by chronic diseases in aging populations. Each modality provides a unique perspective, revealing anatomical structures and functional processes. The growing need for advanced diagnostics in the face of rising chronic disease prevalence among older adults propels the multimodal imaging market forward. Industry analysts anticipate a significant rise in market value.
Technological Advancements in Diagnostics Imaging Modalities
The healthcare landscape is witnessing a pivotal shift towards personalized medicine, demanding ever-more accurate and comprehensive diagnostic tools. The scope of multimodal imaging is where technological advancements in individual imaging modalities are shaping their markets and fueling the explosive growth of a combined force. Integrated scanners combining two or more modalities, like PET/CT or PET/MRI, offer one-stop solutions, streamlining workflows and reducing patient discomfort. Combining information from various modalities gives clinicians a more comprehensive view of disease, leading to earlier and more accurate diagnoses and ultimately improving patient outcomes.
Recent Developments & Partnerships in the Multimodal Imaging Industry
The multimodal imaging market, fueled by the convergence of diverse imaging modalities, is undergoing a period of rapid evolution. Recent developments and strategic partnerships are pushing the boundaries of technology and propelling the market toward broader adoption and impactful applications. Collaborations between pharmaceutical and imaging companies accelerate drug development by utilizing multimodal imaging for early disease detection, target validation, and therapy monitoring. Research institutions and industry players collaborate to translate innovative imaging technologies into clinical practice.
SEGMENTATION INSIGHTS
INSIGHTS BY TECHNOLOGY
The global multimodal imaging market is segmented based on technology into PET/CT, PET/MR, SPECT/CT, OCT/FMT, and others. The PET/CT accounted for the largest market in 2023. PET utilizes radiopharmaceuticals to detect metabolic activity within tissues, aiding in diagnosing and staging cancers, neurological disorders, and cardiovascular diseases. CT offers detailed anatomical information, facilitating the localization and characterization of abnormalities detected on PET scans. PET/CT is widely used in oncology for tumor detection, staging, treatment planning, and response assessment, as well as in cardiology and neurology.
PET/MR offers advantages over PET/CT, including improved soft tissue contrast, reduced radiation exposure, and potential synergistic effects between PET and MRI. PET/MR is utilized in oncology, neurology, and cardiology for applications such as tumor imaging, neurodegenerative disease assessment, and myocardial perfusion imaging. SPECT/CT integrates the functional imaging capabilities of SPECT with the anatomical imaging provided by CT. SPECT/CT is used in nuclear medicine for myocardial perfusion imaging, bone scans, thyroid imaging, and oncological applications. OCT/FMT is applied in ophthalmology for retinal imaging and angiography and in oncology for preclinical research and drug development.
Segmentation by Technology
- PET/CT
- PET/MR
- SPECT/CT
- OCT/FMT
- Others
INSIGHTS BY APPLICATION
The global multimodal imaging market encompasses various diagnostic and clinical applications and applications in biomedical research. From brain & neurology and cardiology to oncology, ophthalmology, obstetrics and gynecology, and beyond, multimodal imaging is pivotal in advancing medical diagnostics, treatment planning, and research across various medical specialties.
Multimodal imaging techniques such as MRI, CT, PET, SPECT, and fMRI are used for the diagnosis and treatment planning of neurological disorders such as stroke, brain tumors, epilepsy, and neurodegenerative diseases. MRI, CT, ultrasound, and molecular imaging are also utilized to assess tumor microstructure, vascularity, and metabolism, guiding personalized treatment approaches and monitoring disease progression. In cardiology, multimodal imaging assesses cardiac structure, function, perfusion, and viability. Techniques such as PET/CT, PET/MRI, echocardiography, cardiac MRI, and coronary CT angiography are utilized to diagnose and manage cardiovascular diseases, including coronary artery disease, heart failure, valvular disorders, and cardiomyopathies.
Segmentation by Application
- Diagnostic & Clinical
- Brain & Neurology
- Oncology
- Cardiology
- Ophthalmology
- Others
- Research
INSIGHTS BY END-USER
The global multimodal imaging market encompasses various end-users, including hospitals, diagnostic imaging centers, research institutions, and others. Each end-user segment contributes uniquely to the market's growth and evolution, fueling demand for advanced multimodal imaging technologies and applications across different medical diagnostics and research domains.
Hospitals represent the largest end-user segment in the global multimodal imaging market. These facilities utilize multimodal imaging systems for diagnostic and therapeutic applications across various medical specialties, including radiology, neurology, cardiology, oncology, ophthalmology, and orthopedics. Diagnostic imaging centers are specialized facilities that provide various imaging services to patients referred by healthcare providers. These centers offer advanced multimodal imaging techniques such as MRI, CT, PET, SPECT, ultrasound, and nuclear medicine imaging. Diagnostic imaging centers are vital in early disease detection, screening, and monitoring, serving as important end-users in the multimodal imaging market.
Segmentation by End-user
- Hospitals
- Diagnostic Imaging Centers
- Academic & Research Centers
- Others
GEOGRAPHICAL ANALYSIS
North America, particularly the US and Canada, dominates the global multimodal imaging market due to well-established healthcare infrastructure, high healthcare spending, and early adoption of advanced medical technologies. The presence of major multinational healthcare companies, research institutions, and academic centers drives innovation and market growth in this region. The demand for multimodal imaging in the region is fueled by the prevalence of chronic diseases, the aging population, an increasing emphasis on early disease detection, and personalized medicine.
Segmentation by Geography
- North America
o The U.S.
o Canada
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Russia
o Netherlands
- APAC
o China
o Japan
o India
o South Korea
o Australia
- Latin America
o Brazil
o Mexico
o Argentina
o Colombia
- Middle East & Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
COMPETITIVE LANDSCAPE
The global multimodal imaging market is a dynamic and fiercely competitive landscape driven by technological advancements, increasing demand for precise diagnostic solutions, and a growing emphasis on personalized healthcare. The global multimodal imaging market is dominated by several key players, each with a significant industry presence and a diverse portfolio of imaging solutions. Some of the leading players in the market include Canon Medical Systems, GE Healthcare, Koninklijke Philips, Siemens Healthineers, and Shimadzu Corporation. Furthermore, leading players invest heavily in research and development to drive innovation in multimodal imaging technologies. This includes developing advanced imaging systems with enhanced capabilities such as AI-driven image analysis, real-time image fusion, and 3D/4D imaging.
Key Company Profiles
- Canon Medical Systems
- GE Healthcare
- Koninklijke Philips
- Shimadzu Corporation
- Siemens Healthineers
Other Prominent Vendors
- Bruker
- Mediso
- MILabs B.V.
- MinFound Medical Systems
- MR Solution
- Shanghai United Imaging Healthcare
- SOFIE
- Spectrum Dynamics Medical
- Topcon
KEY QUESTIONS ANSWERED:
1. How big is the global multimodal imaging market?
2. What is the growth rate of the global multimodal imaging market?
3. Which region dominates the global multimodal imaging market share?
4. What are the significant trends in the global multimodal imaging market?
5. Who are the key players in the global multimodal imaging market?
1. SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. MARKET SEGMENTATION COVERAGE
1.2.1. MARKET BY TECHNOLOGY
1.2.2. MARKET BY APPLICATION
1.2.3. MARKET BY END-USER
1.2.4. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. BASE YEAR
2. PREMIUM INSIGHTS
2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
2.2.1. GEOGRAPHY INSIGHTS
2.2.2. TECHNOLOGY INSIGHTS
2.2.3. APPLICATION INSIGHTS
2.2.4. END-USER INSIGHTS
3. MARKET AT A GLANCE
4. INTRODUCTION
4.1. OVERVIEW
5. MARKET OPPORTUNITIES & TRENDS
5.1. GROWING ADOPTION OF AI & ANALYTICS IN DIAGNOSTIC IMAGING
5.2. MULTIMODAL MOLECULAR IMAGING IN DRUG DISCOVERY AND DEVELOPMENT
5.3. AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE FOR SCANS
6. MARKET GROWTH ENABLERS
6.1. GROWING GERIATRIC POPULATION AND SUBSEQUENT RISE IN CHRONIC CONDITIONS
6.2. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTICS IMAGING MODALITIES
6.3. RECENT DEVELOPMENTS & PARTNERSHIPS IN MULTIMODAL IMAGING INDUSTRY
6.4. NON-INVASIVE IMAGING FUELING GROWTH IN NEUROSCIENCE & ONCOLOGY APPLICATION
7. MARKET RESTRAINTS
7.1. HIGH OPERATING COST OF IMAGING SYSTEMS
7.2. GROWING PREFERENCE FOR REFURBISHED EQUIPMENT
7.3. LACK OF SKILLED PROFESSIONALS
8. MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9. TECHNOLOGY
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. PET/CT
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. PET/CT MARKET BY GEOGRAPHY
9.4. PET/MR
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. PET/MR MARKET BY GEOGRAPHY
9.5. SPECT/CT
9.5.1. MARKET OVERVIEW
9.5.2. MARKET SIZE & FORECAST
9.5.3. SPECT/CT MARKET BY GEOGRAPHY
9.6. OCT/FMT
9.6.1. MARKET OVERVIEW
9.6.2. MARKET SIZE & FORECAST
9.6.3. OCT/FMT MARKET BY GEOGRAPHY
9.7. OTHERS
9.7.1. MARKET OVERVIEW
9.7.2. MARKET SIZE & FORECAST
9.7.3. OTHERS MARKET BY GEOGRAPHY
10. APPLICATION
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. DIAGNOSTIC & CLINICAL
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. DIAGNOSTIC & CLINICAL MARKET BY GEOGRAPHY
10.4. RESEARCH
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. RESEARCH MARKET BY GEOGRAPHY
11. END-USER
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. HOSPITALS
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. HOSPITALS MARKET BY GEOGRAPHY
11.4. DIAGNOSTIC IMAGING CENTERS
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. DIAGNOSTIC IMAGING CENTERS MARKET BY GEOGRAPHY
11.5. ACADEMIC & RESEARCH CENTERS
11.5.1. MARKET OVERVIEW
11.5.2. MARKET SIZE & FORECAST
11.5.3. ACADEMIC & RESEARCH CENTERS MARKET BY GEOGRAPHY
11.6. OTHERS
11.6.1. MARKET OVERVIEW
11.6.2. MARKET SIZE & FORECAST
11.6.3. OTHERS MARKET BY GEOGRAPHY
12. GEOGRAPHY
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. GEOGRAPHIC OVERVIEW
13. NORTH AMERICA
13.1. MARKET OVERVIEW
13.2. MARKET SIZE & FORECAST
13.2.1. NORTH AMERICA MARKET BY TECHNOLOGY
13.2.2. NORTH AMERICA MARKET BY APPLICATION
13.2.3. NORTH AMERICA MARKET BY END-USER
13.3. KEY COUNTRIES
13.3.1. US: MARKET SIZE & FORECAST
13.3.2. CANADA: MARKET SIZE & FORECAST
14. EUROPE
14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.2.1. EUROPE MARKET BY TECHNOLOGY
14.2.2. EUROPE MARKET BY APPLICATION
14.2.3. EUROPE MARKET BY END-USER
14.3. KEY COUNTRIES
14.3.1. GERMANY: MARKET SIZE & FORECAST
14.3.2. FRANCE: MARKET SIZE & FORECAST
14.3.3. UK: MARKET SIZE & FORECAST
14.3.4. ITALY: MARKET SIZE & FORECAST
14.3.5. SPAIN: MARKET SIZE & FORECAST
14.3.6. RUSSIA: MARKET SIZE & FORECAST
14.3.7. NETHERLANDS: MARKET SIZE & FORECAST
15. APAC
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.2.1. APAC MARKET BY TECHNOLOGY
15.2.2. APAC MARKET BY APPLICATION
15.2.3. APAC MARKET BY END-USER
15.3. KEY COUNTRIES
15.3.1. CHINA: MARKET SIZE & FORECAST
15.3.2. JAPAN: MARKET SIZE & FORECAST
15.3.3. INDIA: MARKET SIZE & FORECAST
15.3.4. SOUTH KOREA: MARKET SIZE & FORECAST
15.3.5. AUSTRALIA: MARKET SIZE & FORECAST
16. LATIN AMERICA
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.2.1. LATIN AMERICA MARKET BY TECHNOLOGY
16.2.2. LATIN AMERICA MARKET BY APPLICATION
16.2.3. LATIN AMERICA MARKET BY END-USER
16.3. KEY COUNTRIES
16.3.1. BRAZIL: MARKET SIZE & FORECAST
16.3.2. MEXICO: MARKET SIZE & FORECAST
16.3.3. ARGENTINA: MARKET SIZE & FORECAST
16.3.4. COLOMBIA: MARKET SIZE & FORECAST
17. MIDDLE EAST & AFRICA
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.2.1. MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
17.2.2. MIDDLE EAST & AFRICA MARKET BY APPLICATION
17.2.3. MIDDLE EAST & AFRICA MARKET BY END-USER
17.3. KEY COUNTRIES
17.3.1. TURKEY: MARKET SIZE & FORECAST
17.3.2. SAUDI ARABIA: MARKET SIZE & FORECAST
17.3.3. SOUTH AFRICA: MARKET SIZE & FORECAST
17.3.4. UAE: MARKET SIZE & FORECAST
18. COMPETITIVE LANDSCAPE
18.1. COMPETITION OVERVIEW
18.2. MARKET SHARE ANALYSIS
18.2.1. CANON MEDICAL SYSTEMS
18.2.2. GE HEALTHCARE
18.2.3. KONINKLIJKE PHILIPS
18.2.4. SHIMADZU CORPORATION
18.2.5. SIEMENS HEALTHINEERS
19. KEY COMPANY PROFILES
19.1. CANON MEDICAL SYSTEMS
19.1.1. BUSINESS OVERVIEW
19.1.2. PRODUCT OFFERINGS
19.1.3. KEY STRATEGIES
19.1.4. KEY STRENGTHS
19.1.5. KEY OPPORTUNITIES
19.2. GE HEALTHCARE
19.2.1. BUSINESS OVERVIEW
19.2.2. PRODUCT OFFERINGS
19.2.3. KEY STRATEGIES
19.2.4. KEY STRENGTHS
19.2.5. KEY OPPORTUNITIES
19.3. KONINKLIJKE PHILIPS
19.3.1. BUSINESS OVERVIEW
19.3.2. PRODUCT OFFERINGS
19.3.3. KEY STRATEGIES
19.3.4. KEY STRENGTHS
19.3.5. KEY OPPORTUNITIES
19.4. SHIMADZU CORPORATION
19.4.1. BUSINESS OVERVIEW
19.4.2. PRODUCT OFFERINGS
19.4.3. KEY STRATEGIES
19.4.4. KEY STRENGTHS
19.4.5. KEY OPPORTUNITIES
19.5. SIEMENS HEALTHINEERS
19.5.1. BUSINESS OVERVIEW
19.5.2. PRODUCT OFFERINGS
19.5.3. KEY STRATEGIES
19.5.4. KEY STRENGTHS
19.5.5. KEY OPPORTUNITIES
20. OTHER PROMINENT VENDORS
20.1. BRUKER
20.1.1. BUSINESS OVERVIEW
20.1.2. PRODUCT OFFERINGS
20.2. MEDISO
20.2.1. BUSINESS OVERVIEW
20.2.2. PRODUCT OFFERINGS
20.3. MILABS B.V.
20.3.1. BUSINESS OVERVIEW
20.3.2. PRODUCT OFFERINGS
20.4. MINFOUND MEDICAL SYSTEMS
20.4.1. BUSINESS OVERVIEW
20.4.2. PRODUCT OFFERINGS
20.5. MR SOLUTION
20.5.1. BUSINESS OVERVIEW
20.5.2. PRODUCT OFFERINGS
20.6. SHANGHAI UNITED IMAGING HEALTHCARE
20.6.1. BUSINESS OVERVIEW
20.6.2. PRODUCT OFFERINGS
20.7. SOFIE
20.7.1. BUSINESS OVERVIEW
20.7.2. PRODUCT OFFERINGS
20.8. SPECTRUM DYNAMICS MEDICAL
20.8.1. BUSINESS OVERVIEW
20.8.2. PRODUCT OFFERINGS
20.9. TOPCON
20.9.1. BUSINESS OVERVIEW
20.9.2. PRODUCT OFFERINGS
21. REPORT SUMMARY
21.1. KEY TAKEAWAYS
21.2. STRATEGIC RECOMMENDATIONS
22. QUANTITATIVE SUMMARY
22.1. MARKET BY TECHNOLOGY
22.1.1. NORTH AMERICA MARKET BY TECHNOLOGY
22.1.2. EUROPE MARKET BY TECHNOLOGY
22.1.3. APAC MARKET BY TECHNOLOGY
22.1.4. LATIN AMERICA MARKET BY TECHNOLOGY
22.1.5. MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
22.2. MARKET BY APPLICATION
22.2.1. NORTH AMERICA MARKET BY APPLICATION
22.2.2. EUROPE MARKET BY APPLICATION
22.2.3. APAC MARKET BY APPLICATION
22.2.4. LATIN AMERICA MARKET BY APPLICATION
22.2.5. MIDDLE EAST & AFRICA MARKET BY APPLICATION
22.3. MARKET BY END-USER
22.3.1. NORTH AMERICA MARKET BY END-USER
22.3.2. EUROPE MARKET BY END-USER
22.3.3. APAC MARKET BY END-USER
22.3.4. LATIN AMERICA MARKET BY END-USER
22.3.5. MIDDLE EAST & AFRICA MARKET BY END-USER
22.4. MARKET BY GEOGRAPHY
22.4.1. PET/CT MARKET BY GEOGRAPHY
22.4.2. PET/MR MARKET BY GEOGRAPHY
22.4.3. SPECT/CT MARKET BY GEOGRAPHY
22.4.4. OCT/FMT MARKET BY GEOGRAPHY
22.4.5. OTHERS MARKET BY GEOGRAPHY
22.4.6. DIAGNOSTIC & CLINICAL MARKET BY GEOGRAPHY
22.4.7. RESEARCH MARKET BY GEOGRAPHY
22.4.8. HOSPITALS MARKET BY GEOGRAPHY
22.4.9. DIAGNOSTIC IMAGING CENTERS MARKET BY GEOGRAPHY
22.4.10. ACADEMIC & RESEARCH CENTERS MARKET BY GEOGRAPHY
22.4.11. OTHERS MARKET BY GEOGRAPHY
23. APPENDIX
23.1. RESEARCH METHODOLOGY
23.2. RESEARCH PROCESS
23.3. REPORT ASSUMPTIONS & CAVEATS
23.3.1. KEY CAVEATS
23.3.2. CURRENCY CONVERSION
23.4. ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 3 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 4 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 5 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 6 IMPACT OF GROWING ADOPTION OF AI & ANALYTICS IN DIAGNOSTIC IMAGING
EXHIBIT 7 IMPACT OF MULTIMODAL MOLECULAR IMAGING IN DRUG DISCOVERY AND DEVELOPMENT
EXHIBIT 8 APPLICATIONS OF MULTIMODAL IMAGING ACROSS THE STAGES OF DRUG DISCOVERY & DEVELOPMENT
EXHIBIT 9 IMPACT OF AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE FOR SCANS
EXHIBIT 10 IMPACT OF GROWING GERIATRIC POPULATION AND SUBSEQUENT RISE IN CHRONIC CONDITIONS
EXHIBIT 11 IMPACT OF TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTICS IMAGING MODALITIES
EXHIBIT 12 IMPACT OF RECENT DEVELOPMENTS & PARTNERSHIPS IN MULTIMODAL IMAGING INDUSTRY
EXHIBIT 13 IMPACT OF NON-INVASIVE IMAGING FUELING GROWTH IN NEUROSCIENCE & ONCOLOGY APPLICATION
EXHIBIT 14 IMPACT OF HIGH OPERATING COST OF IMAGING SYSTEMS
EXHIBIT 15 IMPACT OF GROWING PREFERENCE FOR REFURBISHED EQUIPMENT
EXHIBIT 16 IMPACT OF LACK OF SKILLED PROFESSIONALS
EXHIBIT 17 GLOBAL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 18 FIVE FORCES ANALYSIS 2023
EXHIBIT 19 INCREMENTAL GROWTH BY TECHNOLOGY 2023 & 2029
EXHIBIT 20 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 21 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 22 GLOBAL PET/CT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 23 GLOBAL PET/CT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 24 GLOBAL PET/MR MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 25 GLOBAL PET/MR MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 26 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 28 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 30 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 32 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
EXHIBIT 33 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 34 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 35 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL BRAIN & NEUROLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 37 GLOBAL ONCOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 38 GLOBAL CARDIOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 39 GLOBAL OPHTHALMOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 40 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 41 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 42 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 45 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 46 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 47 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 49 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 51 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 53 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 55 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 56 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 57 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 58 NORTH AMERICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 59 NORTH AMERICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 NORTH AMERICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 62 US MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 63 CANADA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 64 EUROPE MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 65 EUROPE MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 EUROPE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 67 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 68 GERMANY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 69 FRANCE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 70 UK MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 71 ITALY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 72 SPAIN MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 73 RUSSIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 74 NETHERLANDS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 75 APAC MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 76 APAC MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 APAC MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 78 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 79 CHINA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 80 JAPAN MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 81 INDIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 82 SOUTH KOREA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 83 AUSTRALIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 84 LATIN AMERICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 85 LATIN AMERICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 86 LATIN AMERICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 87 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 88 BRAZIL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 89 MEXICO MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 90 ARGENTINA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 91 COLOMBIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 92 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 93 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 94 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 95 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 96 TURKEY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 97 SAUDI ARABIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 98 SOUTH AFRICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 99 UAE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 100 VENDORS OFFERING MULTIMODAL IMAGING PRODUCTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 101 VENDORS OFFERING COMMERCIAL MULTIMODAL IMAGING PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 102 KEY CAVEATS
LIST OF EXHIBITS
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 3 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 4 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 5 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 6 IMPACT OF GROWING ADOPTION OF AI & ANALYTICS IN DIAGNOSTIC IMAGING
EXHIBIT 7 IMPACT OF MULTIMODAL MOLECULAR IMAGING IN DRUG DISCOVERY AND DEVELOPMENT
EXHIBIT 8 APPLICATIONS OF MULTIMODAL IMAGING ACROSS THE STAGES OF DRUG DISCOVERY & DEVELOPMENT
EXHIBIT 9 IMPACT OF AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE FOR SCANS
EXHIBIT 10 IMPACT OF GROWING GERIATRIC POPULATION AND SUBSEQUENT RISE IN CHRONIC CONDITIONS
EXHIBIT 11 IMPACT OF TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTICS IMAGING MODALITIES
EXHIBIT 12 IMPACT OF RECENT DEVELOPMENTS & PARTNERSHIPS IN MULTIMODAL IMAGING INDUSTRY
EXHIBIT 13 IMPACT OF NON-INVASIVE IMAGING FUELING GROWTH IN NEUROSCIENCE & ONCOLOGY APPLICATION
EXHIBIT 14 IMPACT OF HIGH OPERATING COST OF IMAGING SYSTEMS
EXHIBIT 15 IMPACT OF GROWING PREFERENCE FOR REFURBISHED EQUIPMENT
EXHIBIT 16 IMPACT OF LACK OF SKILLED PROFESSIONALS
EXHIBIT 17 GLOBAL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 18 FIVE FORCES ANALYSIS 2023
EXHIBIT 19 INCREMENTAL GROWTH BY TECHNOLOGY 2023 & 2029
EXHIBIT 20 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 21 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 22 GLOBAL PET/CT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 23 GLOBAL PET/CT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 24 GLOBAL PET/MR MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 25 GLOBAL PET/MR MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 26 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 28 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 30 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 32 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
EXHIBIT 33 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 34 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 35 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL BRAIN & NEUROLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 37 GLOBAL ONCOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 38 GLOBAL CARDIOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 39 GLOBAL OPHTHALMOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 40 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 41 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 42 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 45 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 46 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 47 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 49 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 51 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 53 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 55 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 56 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 57 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 58 NORTH AMERICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 59 NORTH AMERICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 NORTH AMERICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 62 US MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 63 CANADA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 64 EUROPE MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 65 EUROPE MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 EUROPE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 67 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 68 GERMANY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 69 FRANCE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 70 UK MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 71 ITALY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 72 SPAIN MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 73 RUSSIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 74 NETHERLANDS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 75 APAC MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 76 APAC MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 APAC MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 78 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 79 CHINA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 80 JAPAN MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 81 INDIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 82 SOUTH KOREA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 83 AUSTRALIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 84 LATIN AMERICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 85 LATIN AMERICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 86 LATIN AMERICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 87 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 88 BRAZIL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 89 MEXICO MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 90 ARGENTINA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 91 COLOMBIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 92 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
EXHIBIT 93 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 94 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 95 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 96 TURKEY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 97 SAUDI ARABIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 98 SOUTH AFRICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 99 UAE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
EXHIBIT 100 VENDORS OFFERING MULTIMODAL IMAGING PRODUCTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 101 VENDORS OFFERING COMMERCIAL MULTIMODAL IMAGING PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 102 KEY CAVEATS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security